The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome
Open accessAbstract
Background— Metabolic syndrome importantly accelerates the atherosclerotic process, the earliest event of which is endothelial dysfunction. Ghrelin, a gastric peptide with cardiovascular actions, has been shown to inhibit proatherogenic changes in experimental models. This study therefore investigated whether ghrelin administration might beneficially affect endothelial function in metabolic syndrome. Methods and Results— Endothelium-dependent and -independent vasodilator responses to intra-arterial infusion of increasing doses of acetylcholine and sodium nitroprusside (SNP), respectively, were assessed by strain-gauge plethysmography before and after local administration of human ghrelin (200 μg/min). During saline, the vasodilator response to acetylcholine was significantly blunted ( P =0.008) in patients with metabolic syndrome (n=12, 5 female) compared with controls (n=12, 7 female), whereas the vasodilator response to SNP was not different between groups ( P =0.68). In patients with metabolic syndrome, basal plasma ghrelin was significantly lower than in controls ( P =0.02). In these patients, ghrelin infusion markedly increased intravascular concentrations of the peptide ( P <0.001) and resulted in a potentiation of the vasodilator response to acetylcholine ( P =0.001 versus saline) but not to SNP ( P =0.22). This effect was likely related to enhanced nitric oxide bioavailability because, in a group of patients with metabolic syndrome (n=6, 2 female), ghrelin had no effect on the vasodilator response to acetylcholine ( P =0.78 versus saline) after nitric oxide inhibition by N G -monomethyl- l -arginine. Conclusions— These findings indicate that ghrelin reverses endothelial dysfunction in patients with metabolic syndrome by increasing nitric oxide bioactivity, thereby suggesting that decreased circulating levels of the peptide, such as those found in these patients, might play a role in the pathobiology of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity-induced inflammatory changes in adipose tissue
Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864
Zeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L.-N., Kirby, M., Mostowski, H., & Quon, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1539 · Cited by 745
Cited by
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Metformin: An Old But Still the Best Treatment for Type 2 Diabetes
Rojas, L. B. A., & Gomes, M. B. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-6 · Cited by 567
A novel component of the metabolic syndrome: The oxidative stress
Hopps, E., Noto, D., Caimi, G., & Averna, M. R. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.06.002 · Cited by 335
Mager, U., Kolehmainen, M., de Mello, V. D. F., Schwab, U., Laaksonen, D. E., Rauramaa, R., Gylling, H., Atalay, M., Pulkkinen, L., & Uusitupa, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0862 · Cited by 49
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Reich, N., & Hölscher, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614828 · Cited by 48
“Additionally, clinical studies indicate that AG, in an endothelial nitic oxide synthase (eNOS)-mediated and GH-independent manner, enhances the bioavailability of NO and elicits vasorelaxation, hence improving blood flow and decreasing blood pressure (Nagaya et al., 2001, 2004; Shimizu et al., 2003; Tesauro et al., 20…”
Background
Metadata
- Authors
- Tesauro, M., Schinzari, F., Iantorno, M., Rizza, S., Melina, D., Lauro, D., & Cardillo, C.
- Venue
- Circulation
- Published
- 2005-11-08
- Volume
- 112
- Issue
- 19
- Pages
- 2986-2992
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2155478471
- Cited by
- 205
- References
- 6
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome. https://app.cochat.ai/papers/10.1161/circulationaha.105.553883
- The paper
- Tesauro, M., Schinzari, F., Iantorno, M., Rizza, S., Melina, D., Lauro, D., & Cardillo, C. (2005). Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome. Circulation. https://doi.org/10.1161/circulationaha.105.553883
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.